Project
GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for UUGGCAC
Z-value: 1.72
Motif logo
miRNA associated with seed UUGGCAC
| Name | miRBASE accession |
|---|---|
|
hsa-miR-96-5p
|
MIMAT0000095 |
|
hsa-miR-1271-5p
|
MIMAT0005796 |
Activity profile of UUGGCAC motif
Sorted Z-values of UUGGCAC motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr1_-_20812690 | 41.70 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
| chrX_-_13956737 | 40.53 |
ENST00000454189.2
|
GPM6B
|
glycoprotein M6B |
| chr4_-_176923483 | 37.50 |
ENST00000280187.7
ENST00000512509.1 |
GPM6A
|
glycoprotein M6A |
| chr8_+_80523321 | 31.65 |
ENST00000518111.1
|
STMN2
|
stathmin-like 2 |
| chr16_+_8768422 | 30.71 |
ENST00000268251.8
ENST00000564714.1 |
ABAT
|
4-aminobutyrate aminotransferase |
| chr2_+_203499901 | 24.28 |
ENST00000303116.6
ENST00000392238.2 |
FAM117B
|
family with sequence similarity 117, member B |
| chr3_+_115342159 | 24.13 |
ENST00000305124.6
|
GAP43
|
growth associated protein 43 |
| chr1_+_151043070 | 24.04 |
ENST00000368918.3
ENST00000368917.1 |
GABPB2
|
GA binding protein transcription factor, beta subunit 2 |
| chr14_-_74551172 | 21.33 |
ENST00000553458.1
|
ALDH6A1
|
aldehyde dehydrogenase 6 family, member A1 |
| chr2_+_113033164 | 20.73 |
ENST00000409871.1
ENST00000343936.4 |
ZC3H6
|
zinc finger CCCH-type containing 6 |
| chr5_+_71403061 | 20.61 |
ENST00000512974.1
ENST00000296755.7 |
MAP1B
|
microtubule-associated protein 1B |
| chr7_+_98246588 | 20.58 |
ENST00000265634.3
|
NPTX2
|
neuronal pentraxin II |
| chr15_-_83316254 | 19.93 |
ENST00000567678.1
ENST00000450751.2 |
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
| chr5_+_173472607 | 19.62 |
ENST00000303177.3
ENST00000519867.1 |
NSG2
|
Neuron-specific protein family member 2 |
| chr10_+_105036909 | 19.58 |
ENST00000369849.4
|
INA
|
internexin neuronal intermediate filament protein, alpha |
| chr8_-_134309335 | 19.51 |
ENST00000522890.1
ENST00000323851.7 ENST00000518176.1 ENST00000354944.5 ENST00000537882.1 ENST00000522476.1 ENST00000518066.1 ENST00000521544.1 ENST00000518480.1 ENST00000523892.1 |
NDRG1
|
N-myc downstream regulated 1 |
| chr12_+_113229737 | 19.46 |
ENST00000551052.1
ENST00000415485.3 |
RPH3A
|
rabphilin 3A homolog (mouse) |
| chr17_-_78450398 | 18.81 |
ENST00000306773.4
|
NPTX1
|
neuronal pentraxin I |
| chr17_+_47865917 | 18.66 |
ENST00000259021.4
ENST00000454930.2 ENST00000509773.1 ENST00000510819.1 ENST00000424009.2 |
KAT7
|
K(lysine) acetyltransferase 7 |
| chr6_-_6007200 | 18.44 |
ENST00000244766.2
|
NRN1
|
neuritin 1 |
| chr17_-_79139817 | 18.40 |
ENST00000326724.4
|
AATK
|
apoptosis-associated tyrosine kinase |
| chr22_+_40390930 | 18.37 |
ENST00000333407.6
|
FAM83F
|
family with sequence similarity 83, member F |
| chr4_+_128554081 | 18.00 |
ENST00000335251.6
ENST00000296461.5 |
INTU
|
inturned planar cell polarity protein |
| chrX_+_110339439 | 17.98 |
ENST00000372010.1
ENST00000519681.1 ENST00000372007.5 |
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3 |
| chr9_-_139094988 | 17.73 |
ENST00000371746.3
|
LHX3
|
LIM homeobox 3 |
| chr5_+_17217669 | 17.69 |
ENST00000322611.3
|
BASP1
|
brain abundant, membrane attached signal protein 1 |
| chr19_+_18208603 | 17.43 |
ENST00000262811.6
|
MAST3
|
microtubule associated serine/threonine kinase 3 |
| chr18_-_5544241 | 17.26 |
ENST00000341928.2
ENST00000540638.2 |
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3 |
| chr9_-_104249319 | 17.18 |
ENST00000374847.1
|
TMEM246
|
transmembrane protein 246 |
| chr10_-_15413035 | 17.03 |
ENST00000378116.4
ENST00000455654.1 |
FAM171A1
|
family with sequence similarity 171, member A1 |
| chr12_-_42538657 | 16.98 |
ENST00000398675.3
|
GXYLT1
|
glucoside xylosyltransferase 1 |
| chr11_-_45687128 | 16.86 |
ENST00000308064.2
|
CHST1
|
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
| chr3_-_133614597 | 15.88 |
ENST00000285208.4
ENST00000460865.3 |
RAB6B
|
RAB6B, member RAS oncogene family |
| chr5_-_115910630 | 15.49 |
ENST00000343348.6
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
| chr3_-_56502375 | 15.36 |
ENST00000288221.6
|
ERC2
|
ELKS/RAB6-interacting/CAST family member 2 |
| chr8_+_42752053 | 15.21 |
ENST00000307602.4
|
HOOK3
|
hook microtubule-tethering protein 3 |
| chr9_-_139922631 | 15.14 |
ENST00000341511.6
|
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2 |
| chr10_+_104613980 | 15.14 |
ENST00000339834.5
|
C10orf32
|
chromosome 10 open reading frame 32 |
| chr2_-_220110187 | 14.88 |
ENST00000295759.7
ENST00000392089.2 |
GLB1L
|
galactosidase, beta 1-like |
| chr4_+_47033345 | 14.85 |
ENST00000295454.3
|
GABRB1
|
gamma-aminobutyric acid (GABA) A receptor, beta 1 |
| chr17_+_57232690 | 14.78 |
ENST00000262293.4
|
PRR11
|
proline rich 11 |
| chr7_-_111846435 | 14.64 |
ENST00000437633.1
ENST00000428084.1 |
DOCK4
|
dedicator of cytokinesis 4 |
| chr1_-_41131326 | 14.61 |
ENST00000372684.3
|
RIMS3
|
regulating synaptic membrane exocytosis 3 |
| chr2_-_44588893 | 14.47 |
ENST00000409272.1
ENST00000410081.1 ENST00000541738.1 |
PREPL
|
prolyl endopeptidase-like |
| chr10_+_92980517 | 14.38 |
ENST00000336126.5
|
PCGF5
|
polycomb group ring finger 5 |
| chr5_+_152870106 | 14.31 |
ENST00000285900.5
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1 |
| chr20_-_50384864 | 14.27 |
ENST00000311637.5
ENST00000402822.1 |
ATP9A
|
ATPase, class II, type 9A |
| chr8_+_58907104 | 14.19 |
ENST00000361488.3
|
FAM110B
|
family with sequence similarity 110, member B |
| chr16_+_12070567 | 14.08 |
ENST00000566228.1
|
SNX29
|
sorting nexin 29 |
| chr11_-_73309228 | 14.06 |
ENST00000356467.4
ENST00000064778.4 |
FAM168A
|
family with sequence similarity 168, member A |
| chr12_-_124457371 | 13.95 |
ENST00000238156.3
ENST00000545037.1 |
CCDC92
|
coiled-coil domain containing 92 |
| chr3_-_170303845 | 13.93 |
ENST00000231706.5
|
SLC7A14
|
solute carrier family 7, member 14 |
| chr12_-_57914275 | 13.85 |
ENST00000547303.1
ENST00000552740.1 ENST00000547526.1 ENST00000551116.1 ENST00000346473.3 |
DDIT3
|
DNA-damage-inducible transcript 3 |
| chr22_+_31031639 | 13.80 |
ENST00000343605.4
ENST00000300385.8 |
SLC35E4
|
solute carrier family 35, member E4 |
| chr3_+_138066539 | 13.63 |
ENST00000289104.4
|
MRAS
|
muscle RAS oncogene homolog |
| chr8_+_120885949 | 13.50 |
ENST00000523492.1
ENST00000286234.5 |
DEPTOR
|
DEP domain containing MTOR-interacting protein |
| chr13_+_58206655 | 12.99 |
ENST00000377918.3
|
PCDH17
|
protocadherin 17 |
| chr22_-_36903101 | 12.87 |
ENST00000397224.4
|
FOXRED2
|
FAD-dependent oxidoreductase domain containing 2 |
| chr1_-_115212696 | 12.73 |
ENST00000393276.3
ENST00000393277.1 |
DENND2C
|
DENN/MADD domain containing 2C |
| chrX_+_44732757 | 12.66 |
ENST00000377967.4
ENST00000536777.1 ENST00000382899.4 ENST00000543216.1 |
KDM6A
|
lysine (K)-specific demethylase 6A |
| chr1_+_50574585 | 12.44 |
ENST00000371824.1
ENST00000371823.4 |
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4 |
| chr15_+_51200859 | 12.22 |
ENST00000261842.5
|
AP4E1
|
adaptor-related protein complex 4, epsilon 1 subunit |
| chr2_+_173600671 | 12.02 |
ENST00000409036.1
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
| chr1_+_78245303 | 11.89 |
ENST00000370791.3
ENST00000443751.2 |
FAM73A
|
family with sequence similarity 73, member A |
| chr17_-_1532106 | 11.84 |
ENST00000301335.5
ENST00000382147.4 |
SLC43A2
|
solute carrier family 43 (amino acid system L transporter), member 2 |
| chr7_+_87257701 | 11.56 |
ENST00000338056.3
ENST00000493037.1 |
RUNDC3B
|
RUN domain containing 3B |
| chr17_-_34890759 | 11.42 |
ENST00000431794.3
|
MYO19
|
myosin XIX |
| chr1_-_15911510 | 11.40 |
ENST00000375826.3
|
AGMAT
|
agmatine ureohydrolase (agmatinase) |
| chrX_-_40594755 | 11.38 |
ENST00000324817.1
|
MED14
|
mediator complex subunit 14 |
| chr4_-_16900217 | 11.29 |
ENST00000441778.2
|
LDB2
|
LIM domain binding 2 |
| chr2_+_32502952 | 11.27 |
ENST00000238831.4
|
YIPF4
|
Yip1 domain family, member 4 |
| chr2_+_46524537 | 11.21 |
ENST00000263734.3
|
EPAS1
|
endothelial PAS domain protein 1 |
| chr11_-_115375107 | 11.04 |
ENST00000545380.1
ENST00000452722.3 ENST00000537058.1 ENST00000536727.1 ENST00000542447.2 ENST00000331581.6 |
CADM1
|
cell adhesion molecule 1 |
| chr16_-_19896220 | 11.03 |
ENST00000562469.1
ENST00000300571.2 |
GPRC5B
|
G protein-coupled receptor, family C, group 5, member B |
| chr14_+_74111578 | 10.97 |
ENST00000554113.1
ENST00000555631.2 ENST00000553645.2 ENST00000311089.3 ENST00000555919.3 ENST00000554339.1 ENST00000554871.1 |
DNAL1
|
dynein, axonemal, light chain 1 |
| chr21_-_32931290 | 10.93 |
ENST00000286827.3
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1 |
| chrX_+_70316005 | 10.93 |
ENST00000374259.3
|
FOXO4
|
forkhead box O4 |
| chr3_-_57678772 | 10.90 |
ENST00000311128.5
|
DENND6A
|
DENN/MADD domain containing 6A |
| chr5_+_76506706 | 10.79 |
ENST00000340978.3
ENST00000346042.3 ENST00000264917.5 ENST00000342343.4 ENST00000333194.4 |
PDE8B
|
phosphodiesterase 8B |
| chr7_+_87563458 | 10.76 |
ENST00000398204.4
|
ADAM22
|
ADAM metallopeptidase domain 22 |
| chr20_+_44657845 | 10.75 |
ENST00000243964.3
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5 |
| chr5_+_75378997 | 10.61 |
ENST00000502798.2
|
SV2C
|
synaptic vesicle glycoprotein 2C |
| chr2_+_219824357 | 10.60 |
ENST00000302625.4
|
CDK5R2
|
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
| chr7_-_158380465 | 10.52 |
ENST00000389413.3
ENST00000409483.1 |
PTPRN2
|
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
| chrX_+_122993827 | 10.47 |
ENST00000371199.3
|
XIAP
|
X-linked inhibitor of apoptosis |
| chr10_+_104629199 | 10.39 |
ENST00000369880.3
|
AS3MT
|
arsenic (+3 oxidation state) methyltransferase |
| chr2_-_201936302 | 10.29 |
ENST00000453765.1
ENST00000452799.1 ENST00000446678.1 ENST00000418596.3 |
FAM126B
|
family with sequence similarity 126, member B |
| chr6_-_34360413 | 10.28 |
ENST00000607016.1
|
NUDT3
|
nudix (nucleoside diphosphate linked moiety X)-type motif 3 |
| chr9_+_4490394 | 10.25 |
ENST00000262352.3
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
| chr17_+_17942594 | 10.23 |
ENST00000268719.4
|
GID4
|
GID complex subunit 4 |
| chr13_+_24734844 | 10.00 |
ENST00000382108.3
|
SPATA13
|
spermatogenesis associated 13 |
| chr9_+_130159504 | 9.73 |
ENST00000373352.1
ENST00000373360.3 |
SLC2A8
|
solute carrier family 2 (facilitated glucose transporter), member 8 |
| chr1_-_109584608 | 9.52 |
ENST00000400794.3
ENST00000528747.1 ENST00000369962.3 ENST00000361054.3 |
WDR47
|
WD repeat domain 47 |
| chr6_+_69345166 | 9.48 |
ENST00000370598.1
|
BAI3
|
brain-specific angiogenesis inhibitor 3 |
| chr11_-_64570706 | 9.45 |
ENST00000294066.2
ENST00000377350.3 |
MAP4K2
|
mitogen-activated protein kinase kinase kinase kinase 2 |
| chr9_-_23821273 | 9.44 |
ENST00000380110.4
|
ELAVL2
|
ELAV like neuron-specific RNA binding protein 2 |
| chr11_-_31839488 | 9.33 |
ENST00000419022.1
ENST00000379132.3 ENST00000379129.2 |
PAX6
|
paired box 6 |
| chr6_+_17600576 | 9.28 |
ENST00000259963.3
|
FAM8A1
|
family with sequence similarity 8, member A1 |
| chr4_+_86396265 | 9.21 |
ENST00000395184.1
|
ARHGAP24
|
Rho GTPase activating protein 24 |
| chrX_+_23352133 | 9.07 |
ENST00000379361.4
|
PTCHD1
|
patched domain containing 1 |
| chr19_-_18632861 | 9.07 |
ENST00000262809.4
|
ELL
|
elongation factor RNA polymerase II |
| chr2_-_183903133 | 9.02 |
ENST00000361354.4
|
NCKAP1
|
NCK-associated protein 1 |
| chr2_-_152955537 | 8.99 |
ENST00000201943.5
ENST00000539935.1 |
CACNB4
|
calcium channel, voltage-dependent, beta 4 subunit |
| chr3_-_66551351 | 8.92 |
ENST00000273261.3
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1 |
| chr1_-_86043921 | 8.89 |
ENST00000535924.2
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1 |
| chr2_-_101034070 | 8.88 |
ENST00000264249.3
|
CHST10
|
carbohydrate sulfotransferase 10 |
| chr17_+_73043301 | 8.87 |
ENST00000322444.6
|
KCTD2
|
potassium channel tetramerization domain containing 2 |
| chr6_-_169654139 | 8.76 |
ENST00000366787.3
|
THBS2
|
thrombospondin 2 |
| chr14_+_105781048 | 8.59 |
ENST00000458164.2
ENST00000447393.1 |
PACS2
|
phosphofurin acidic cluster sorting protein 2 |
| chr4_-_90229142 | 8.55 |
ENST00000609438.1
|
GPRIN3
|
GPRIN family member 3 |
| chr6_+_138483058 | 8.37 |
ENST00000251691.4
|
KIAA1244
|
KIAA1244 |
| chr12_+_6961279 | 8.33 |
ENST00000229268.8
ENST00000389231.5 ENST00000542087.1 |
USP5
|
ubiquitin specific peptidase 5 (isopeptidase T) |
| chr1_-_16678914 | 8.27 |
ENST00000375592.3
|
FBXO42
|
F-box protein 42 |
| chr2_-_218808771 | 8.23 |
ENST00000449814.1
ENST00000171887.4 |
TNS1
|
tensin 1 |
| chr15_+_75118888 | 8.19 |
ENST00000395018.4
|
CPLX3
|
complexin 3 |
| chr2_+_166095898 | 8.07 |
ENST00000424833.1
ENST00000375437.2 ENST00000357398.3 |
SCN2A
|
sodium channel, voltage-gated, type II, alpha subunit |
| chr4_-_88141755 | 7.98 |
ENST00000273963.5
|
KLHL8
|
kelch-like family member 8 |
| chr4_+_78078304 | 7.94 |
ENST00000316355.5
ENST00000354403.5 ENST00000502280.1 |
CCNG2
|
cyclin G2 |
| chr2_+_231902193 | 7.77 |
ENST00000373640.4
|
C2orf72
|
chromosome 2 open reading frame 72 |
| chr16_+_50775948 | 7.77 |
ENST00000569681.1
ENST00000569418.1 ENST00000540145.1 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
| chr3_-_114790179 | 7.74 |
ENST00000462705.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
| chr8_+_1449532 | 7.72 |
ENST00000421627.2
|
DLGAP2
|
discs, large (Drosophila) homolog-associated protein 2 |
| chr12_-_104234966 | 7.71 |
ENST00000392876.3
|
NT5DC3
|
5'-nucleotidase domain containing 3 |
| chr1_+_109792641 | 7.68 |
ENST00000271332.3
|
CELSR2
|
cadherin, EGF LAG seven-pass G-type receptor 2 |
| chr10_-_11653753 | 7.55 |
ENST00000609104.1
|
USP6NL
|
USP6 N-terminal like |
| chr18_-_53255766 | 7.54 |
ENST00000566286.1
ENST00000564999.1 ENST00000566279.1 ENST00000354452.3 ENST00000356073.4 |
TCF4
|
transcription factor 4 |
| chr13_+_98794810 | 7.50 |
ENST00000595437.1
|
FARP1
|
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) |
| chr2_+_118846008 | 7.50 |
ENST00000245787.4
|
INSIG2
|
insulin induced gene 2 |
| chr14_-_103523745 | 7.47 |
ENST00000361246.2
|
CDC42BPB
|
CDC42 binding protein kinase beta (DMPK-like) |
| chr19_+_1752372 | 7.42 |
ENST00000382349.4
|
ONECUT3
|
one cut homeobox 3 |
| chr14_+_75536280 | 7.37 |
ENST00000238686.8
|
ZC2HC1C
|
zinc finger, C2HC-type containing 1C |
| chr12_+_69864129 | 7.33 |
ENST00000547219.1
ENST00000299293.2 ENST00000549921.1 ENST00000550316.1 ENST00000548154.1 ENST00000547414.1 ENST00000550389.1 ENST00000550937.1 ENST00000549092.1 ENST00000550169.1 |
FRS2
|
fibroblast growth factor receptor substrate 2 |
| chr9_+_104161123 | 7.32 |
ENST00000374861.3
ENST00000339664.2 ENST00000259395.4 |
ZNF189
|
zinc finger protein 189 |
| chr3_+_39851094 | 7.32 |
ENST00000302541.6
|
MYRIP
|
myosin VIIA and Rab interacting protein |
| chrX_-_107979616 | 7.25 |
ENST00000372129.2
|
IRS4
|
insulin receptor substrate 4 |
| chr10_+_95517566 | 7.24 |
ENST00000542308.1
|
LGI1
|
leucine-rich, glioma inactivated 1 |
| chr11_+_70244510 | 7.20 |
ENST00000346329.3
ENST00000301843.8 ENST00000376561.3 |
CTTN
|
cortactin |
| chr3_+_4535025 | 7.13 |
ENST00000302640.8
ENST00000354582.6 ENST00000423119.2 ENST00000357086.4 ENST00000456211.2 |
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1 |
| chr19_-_10341948 | 7.13 |
ENST00000590320.1
ENST00000592342.1 ENST00000588952.1 |
S1PR2
DNMT1
|
sphingosine-1-phosphate receptor 2 DNA (cytosine-5-)-methyltransferase 1 |
| chr10_+_104678032 | 7.00 |
ENST00000369878.4
ENST00000369875.3 |
CNNM2
|
cyclin M2 |
| chr2_+_207308220 | 7.00 |
ENST00000264377.3
|
ADAM23
|
ADAM metallopeptidase domain 23 |
| chr12_-_120554534 | 7.00 |
ENST00000538903.1
ENST00000534951.1 |
RAB35
|
RAB35, member RAS oncogene family |
| chr10_+_120789223 | 6.98 |
ENST00000425699.1
|
NANOS1
|
nanos homolog 1 (Drosophila) |
| chr1_-_109940550 | 6.92 |
ENST00000256637.6
|
SORT1
|
sortilin 1 |
| chr17_+_77751931 | 6.91 |
ENST00000310942.4
ENST00000269399.5 |
CBX2
|
chromobox homolog 2 |
| chr2_-_86564776 | 6.90 |
ENST00000165698.5
ENST00000541910.1 ENST00000535845.1 |
REEP1
|
receptor accessory protein 1 |
| chr5_-_171433819 | 6.90 |
ENST00000296933.6
|
FBXW11
|
F-box and WD repeat domain containing 11 |
| chr11_+_92085262 | 6.89 |
ENST00000298047.6
ENST00000409404.2 ENST00000541502.1 |
FAT3
|
FAT atypical cadherin 3 |
| chr2_-_73340146 | 6.80 |
ENST00000258098.6
|
RAB11FIP5
|
RAB11 family interacting protein 5 (class I) |
| chr22_+_30792846 | 6.66 |
ENST00000312932.9
ENST00000428195.1 |
SEC14L2
|
SEC14-like 2 (S. cerevisiae) |
| chr2_+_173940442 | 6.65 |
ENST00000409176.2
ENST00000338983.3 ENST00000431503.2 |
MLTK
|
Mitogen-activated protein kinase kinase kinase MLT |
| chrX_+_136648297 | 6.63 |
ENST00000287538.5
|
ZIC3
|
Zic family member 3 |
| chr15_+_31619013 | 6.59 |
ENST00000307145.3
|
KLF13
|
Kruppel-like factor 13 |
| chr3_-_50540854 | 6.58 |
ENST00000423994.2
ENST00000424201.2 ENST00000479441.1 ENST00000429770.1 |
CACNA2D2
|
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
| chr9_-_140115775 | 6.57 |
ENST00000391553.1
ENST00000392827.1 |
RNF208
|
ring finger protein 208 |
| chr6_-_34664612 | 6.54 |
ENST00000374023.3
ENST00000374026.3 |
C6orf106
|
chromosome 6 open reading frame 106 |
| chr1_+_205473720 | 6.45 |
ENST00000429964.2
ENST00000506784.1 ENST00000360066.2 |
CDK18
|
cyclin-dependent kinase 18 |
| chr8_+_37654424 | 6.39 |
ENST00000315215.7
|
GPR124
|
G protein-coupled receptor 124 |
| chr6_-_39197226 | 6.37 |
ENST00000359534.3
|
KCNK5
|
potassium channel, subfamily K, member 5 |
| chr19_-_14316980 | 6.30 |
ENST00000361434.3
ENST00000340736.6 |
LPHN1
|
latrophilin 1 |
| chr14_+_105331596 | 6.22 |
ENST00000556508.1
ENST00000414716.3 ENST00000453495.1 ENST00000418279.1 |
CEP170B
|
centrosomal protein 170B |
| chr17_-_74722672 | 6.19 |
ENST00000397625.4
ENST00000445478.2 |
JMJD6
|
jumonji domain containing 6 |
| chr8_-_22550815 | 6.13 |
ENST00000317216.2
|
EGR3
|
early growth response 3 |
| chr2_+_241375069 | 6.13 |
ENST00000264039.2
|
GPC1
|
glypican 1 |
| chr2_-_30144432 | 6.11 |
ENST00000389048.3
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase |
| chr5_-_114598548 | 6.09 |
ENST00000379615.3
ENST00000419445.1 |
PGGT1B
|
protein geranylgeranyltransferase type I, beta subunit |
| chr15_-_72410109 | 6.04 |
ENST00000564571.1
|
MYO9A
|
myosin IXA |
| chr3_-_15374033 | 6.02 |
ENST00000253688.5
ENST00000383791.3 |
SH3BP5
|
SH3-domain binding protein 5 (BTK-associated) |
| chr14_-_51562745 | 5.92 |
ENST00000298355.3
|
TRIM9
|
tripartite motif containing 9 |
| chr2_-_213403565 | 5.85 |
ENST00000342788.4
ENST00000436443.1 |
ERBB4
|
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 |
| chr7_-_51384451 | 5.84 |
ENST00000441453.1
ENST00000265136.7 ENST00000395542.2 ENST00000395540.2 |
COBL
|
cordon-bleu WH2 repeat protein |
| chrX_+_37208521 | 5.79 |
ENST00000378628.4
|
PRRG1
|
proline rich Gla (G-carboxyglutamic acid) 1 |
| chr21_-_42219065 | 5.76 |
ENST00000400454.1
|
DSCAM
|
Down syndrome cell adhesion molecule |
| chr13_-_41240717 | 5.67 |
ENST00000379561.5
|
FOXO1
|
forkhead box O1 |
| chr1_-_201915590 | 5.66 |
ENST00000367288.4
|
LMOD1
|
leiomodin 1 (smooth muscle) |
| chr19_+_3094398 | 5.62 |
ENST00000078429.4
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class) |
| chr1_-_202858227 | 5.61 |
ENST00000367262.3
|
RABIF
|
RAB interacting factor |
| chr12_-_54673871 | 5.58 |
ENST00000209875.4
|
CBX5
|
chromobox homolog 5 |
| chr13_-_53422640 | 5.56 |
ENST00000338862.4
ENST00000377942.3 |
PCDH8
|
protocadherin 8 |
| chr1_+_200708671 | 5.37 |
ENST00000358823.2
|
CAMSAP2
|
calmodulin regulated spectrin-associated protein family, member 2 |
| chr9_-_125675576 | 5.37 |
ENST00000373659.3
|
ZBTB6
|
zinc finger and BTB domain containing 6 |
| chr7_+_66093851 | 5.35 |
ENST00000275532.3
|
KCTD7
|
potassium channel tetramerization domain containing 7 |
| chr5_-_95297678 | 5.33 |
ENST00000237853.4
|
ELL2
|
elongation factor, RNA polymerase II, 2 |
| chrX_-_133119895 | 5.31 |
ENST00000370818.3
|
GPC3
|
glypican 3 |
| chr2_-_167232484 | 5.30 |
ENST00000375387.4
ENST00000303354.6 ENST00000409672.1 |
SCN9A
|
sodium channel, voltage-gated, type IX, alpha subunit |
| chr15_-_34628951 | 5.29 |
ENST00000397707.2
ENST00000560611.1 |
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6 |
| chr2_-_166060571 | 5.28 |
ENST00000360093.3
|
SCN3A
|
sodium channel, voltage-gated, type III, alpha subunit |
| chr12_+_57943781 | 5.26 |
ENST00000455537.2
ENST00000286452.5 |
KIF5A
|
kinesin family member 5A |
| chr16_-_29910365 | 5.25 |
ENST00000346932.5
ENST00000350527.3 ENST00000537485.1 ENST00000568380.1 |
SEZ6L2
|
seizure related 6 homolog (mouse)-like 2 |
| chr10_-_70287231 | 5.19 |
ENST00000609923.1
|
SLC25A16
|
solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16 |
| chr13_-_20735178 | 5.18 |
ENST00000241125.3
|
GJA3
|
gap junction protein, alpha 3, 46kDa |
| chr1_-_177133818 | 5.18 |
ENST00000424564.2
ENST00000361833.2 |
ASTN1
|
astrotactin 1 |
| chr12_+_55413721 | 5.15 |
ENST00000242994.3
|
NEUROD4
|
neuronal differentiation 4 |
| chr1_+_113615794 | 5.15 |
ENST00000361127.5
|
LRIG2
|
leucine-rich repeats and immunoglobulin-like domains 2 |
| chr11_+_111473108 | 5.15 |
ENST00000304987.3
|
SIK2
|
salt-inducible kinase 2 |
| chr12_-_93323013 | 5.10 |
ENST00000322349.8
|
EEA1
|
early endosome antigen 1 |
| chr5_+_118407053 | 5.02 |
ENST00000311085.8
ENST00000539542.1 |
DMXL1
|
Dmx-like 1 |
| chr2_-_166930131 | 4.88 |
ENST00000303395.4
ENST00000409050.1 ENST00000423058.2 ENST00000375405.3 |
SCN1A
|
sodium channel, voltage-gated, type I, alpha subunit |
| chr17_+_36508111 | 4.88 |
ENST00000331159.5
ENST00000577233.1 |
SOCS7
|
suppressor of cytokine signaling 7 |
| chr9_-_115480303 | 4.88 |
ENST00000374234.1
ENST00000374238.1 ENST00000374236.1 ENST00000374242.4 |
INIP
|
INTS3 and NABP interacting protein |
Network of associatons between targets according to the STRING database.
First level regulatory network of UUGGCAC
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.9 | 31.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 7.7 | 30.7 | GO:1904450 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 5.3 | 21.3 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 4.7 | 18.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 4.2 | 12.7 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 4.1 | 40.5 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 3.8 | 15.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 3.7 | 3.7 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 3.5 | 17.7 | GO:2001076 | regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 3.5 | 10.6 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 3.5 | 10.5 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 3.0 | 8.9 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 3.0 | 17.7 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 2.9 | 14.6 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
| 2.9 | 5.8 | GO:2000364 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 2.8 | 11.4 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 2.8 | 13.8 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
| 2.8 | 11.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 2.7 | 10.9 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 2.7 | 10.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 2.6 | 7.8 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 2.5 | 17.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 2.4 | 7.3 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
| 2.4 | 24.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 2.4 | 12.0 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 2.3 | 9.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 2.2 | 2.2 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
| 2.2 | 18.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 2.2 | 11.2 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 2.2 | 6.7 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
| 2.2 | 6.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 2.1 | 4.2 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
| 2.1 | 10.3 | GO:1901910 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 2.0 | 6.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 2.0 | 19.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 2.0 | 19.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 1.9 | 18.8 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 1.9 | 9.3 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 1.9 | 13.0 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
| 1.8 | 10.9 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
| 1.8 | 14.5 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 1.8 | 7.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 1.8 | 5.3 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 1.7 | 3.4 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 1.7 | 21.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 1.5 | 6.1 | GO:0036269 | swimming behavior(GO:0036269) |
| 1.5 | 4.6 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 1.5 | 4.5 | GO:1901994 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 1.5 | 5.8 | GO:0001757 | somite specification(GO:0001757) |
| 1.4 | 4.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 1.4 | 1.4 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 1.4 | 10.1 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 1.4 | 7.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 1.4 | 5.7 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
| 1.4 | 15.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 1.4 | 15.3 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 1.4 | 4.1 | GO:1902287 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 1.3 | 5.3 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 1.3 | 5.3 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 1.3 | 10.2 | GO:0070777 | sulfur amino acid transport(GO:0000101) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 1.2 | 6.1 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 1.2 | 11.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 1.2 | 14.6 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 1.2 | 4.8 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 1.2 | 8.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 1.1 | 18.0 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
| 1.1 | 3.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 1.1 | 6.6 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of digestive tract left/right asymmetry(GO:0071907) |
| 1.1 | 4.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 1.1 | 7.7 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
| 1.1 | 2.2 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 1.1 | 3.2 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 1.0 | 2.1 | GO:0002537 | nitric oxide production involved in inflammatory response(GO:0002537) |
| 1.0 | 3.0 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 1.0 | 4.0 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 1.0 | 9.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 1.0 | 3.0 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
| 1.0 | 5.9 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 1.0 | 6.8 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 1.0 | 2.9 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 0.9 | 5.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.9 | 33.6 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.9 | 3.6 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
| 0.9 | 7.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.9 | 8.0 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
| 0.9 | 9.8 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.9 | 5.2 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.9 | 3.4 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.8 | 2.5 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.8 | 16.9 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.8 | 34.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.8 | 5.8 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.8 | 1.6 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.8 | 2.4 | GO:0001554 | luteolysis(GO:0001554) |
| 0.8 | 3.9 | GO:0003431 | growth plate cartilage chondrocyte growth(GO:0003430) growth plate cartilage chondrocyte development(GO:0003431) Harderian gland development(GO:0070384) |
| 0.8 | 2.3 | GO:2001045 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.8 | 6.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.8 | 14.5 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.7 | 14.9 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.7 | 2.2 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 0.7 | 11.0 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.7 | 17.6 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.7 | 4.4 | GO:0016577 | histone demethylation(GO:0016577) |
| 0.7 | 2.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) fasciculation of motor neuron axon(GO:0097156) |
| 0.7 | 8.9 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.7 | 14.2 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 0.7 | 4.0 | GO:0021764 | amygdala development(GO:0021764) |
| 0.7 | 7.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.6 | 19.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.6 | 8.1 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.6 | 7.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.6 | 4.2 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.6 | 1.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.6 | 13.8 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.6 | 10.8 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.6 | 3.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.6 | 6.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.6 | 1.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.6 | 1.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.6 | 8.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.5 | 4.9 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.5 | 8.1 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 0.5 | 6.9 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.5 | 11.4 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 0.5 | 5.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.5 | 2.6 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.5 | 4.1 | GO:0002118 | aggressive behavior(GO:0002118) |
| 0.5 | 15.6 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.5 | 11.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.5 | 12.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
| 0.5 | 6.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.5 | 2.9 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.5 | 2.8 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.5 | 9.7 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.5 | 5.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.5 | 4.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.4 | 0.9 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.4 | 1.3 | GO:0035627 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.4 | 4.9 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.4 | 4.0 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.4 | 3.9 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.4 | 10.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.4 | 4.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.4 | 13.6 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.4 | 3.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.4 | 12.9 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.4 | 1.2 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.4 | 8.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.4 | 2.5 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.4 | 2.8 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.4 | 0.7 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.4 | 4.9 | GO:0021794 | thalamus development(GO:0021794) |
| 0.4 | 2.8 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.3 | 4.2 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.3 | 3.5 | GO:1901621 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.3 | 1.4 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
| 0.3 | 1.0 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.3 | 5.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.3 | 1.0 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
| 0.3 | 2.9 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.3 | 1.0 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) |
| 0.3 | 2.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.3 | 6.9 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.3 | 2.9 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.3 | 2.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
| 0.3 | 8.2 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
| 0.3 | 2.5 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.3 | 3.3 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.3 | 11.7 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.3 | 4.2 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.3 | 2.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.3 | 1.3 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.3 | 1.8 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.2 | 14.1 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
| 0.2 | 16.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.2 | 3.1 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.2 | 13.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.2 | 0.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.2 | 2.0 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
| 0.2 | 3.5 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 0.2 | 10.6 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.2 | 6.0 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.2 | 0.2 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
| 0.2 | 5.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.2 | 1.4 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.2 | 2.3 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.2 | 3.1 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
| 0.2 | 6.5 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 0.2 | 4.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.2 | 20.2 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.2 | 0.9 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.2 | 7.0 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.2 | 5.2 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.2 | 8.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.2 | 3.3 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.2 | 0.3 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.1 | 0.8 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
| 0.1 | 16.4 | GO:0006836 | neurotransmitter transport(GO:0006836) |
| 0.1 | 20.1 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
| 0.1 | 3.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 | 1.4 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 | 0.4 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
| 0.1 | 1.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.1 | 1.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 11.0 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.1 | 4.8 | GO:1901998 | toxin transport(GO:1901998) |
| 0.1 | 6.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.1 | 7.5 | GO:0008306 | associative learning(GO:0008306) |
| 0.1 | 1.9 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 | 0.3 | GO:2000282 | regulation of arginine metabolic process(GO:0000821) regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of adrenergic receptor signaling pathway(GO:0071878) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) regulation of cellular amino acid biosynthetic process(GO:2000282) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 0.1 | 0.6 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.1 | 0.9 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
| 0.1 | 3.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 | 0.9 | GO:0021549 | cerebellum development(GO:0021549) |
| 0.1 | 1.5 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.1 | 3.4 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.1 | 2.9 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.1 | 0.5 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 1.6 | GO:0003416 | endochondral bone growth(GO:0003416) |
| 0.1 | 1.6 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
| 0.1 | 2.3 | GO:0019216 | regulation of lipid metabolic process(GO:0019216) |
| 0.1 | 0.1 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
| 0.1 | 9.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 | 0.9 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.1 | 21.5 | GO:0051260 | protein homooligomerization(GO:0051260) |
| 0.1 | 1.1 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.1 | 3.0 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
| 0.1 | 3.3 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.1 | 1.3 | GO:0097503 | sialylation(GO:0097503) |
| 0.1 | 3.3 | GO:0051262 | protein tetramerization(GO:0051262) |
| 0.1 | 1.8 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.1 | 11.2 | GO:0007601 | visual perception(GO:0007601) |
| 0.1 | 4.5 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 | 0.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.1 | 1.9 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.0 | 2.0 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.0 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.0 | 4.2 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
| 0.0 | 2.9 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.0 | 0.6 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
| 0.0 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.0 | 0.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.0 | 0.6 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.0 | 0.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.0 | 2.7 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
| 0.0 | 0.6 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.0 | 1.8 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
| 0.0 | 1.5 | GO:0030282 | bone mineralization(GO:0030282) |
| 0.0 | 0.8 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.0 | 0.7 | GO:0021987 | cerebral cortex development(GO:0021987) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.7 | 30.7 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 4.6 | 13.8 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 3.9 | 19.4 | GO:0044308 | axonal spine(GO:0044308) |
| 3.8 | 15.2 | GO:0070695 | FHF complex(GO:0070695) |
| 3.4 | 24.1 | GO:0032584 | growth cone membrane(GO:0032584) |
| 2.6 | 10.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 2.5 | 50.1 | GO:0044295 | axonal growth cone(GO:0044295) |
| 2.3 | 11.4 | GO:0070847 | core mediator complex(GO:0070847) |
| 2.0 | 6.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 1.9 | 7.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 1.7 | 5.0 | GO:0043291 | RAVE complex(GO:0043291) |
| 1.5 | 25.3 | GO:0033270 | paranode region of axon(GO:0033270) |
| 1.5 | 22.0 | GO:0005883 | neurofilament(GO:0005883) |
| 1.4 | 11.0 | GO:0036157 | outer dynein arm(GO:0036157) |
| 1.4 | 4.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 1.3 | 15.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 1.2 | 4.9 | GO:0070876 | SOSS complex(GO:0070876) |
| 1.2 | 12.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 1.1 | 15.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 1.1 | 5.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.9 | 3.8 | GO:1990745 | EARP complex(GO:1990745) |
| 0.9 | 18.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.9 | 4.6 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.8 | 7.6 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.8 | 3.1 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.8 | 3.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.8 | 37.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.7 | 2.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.7 | 9.0 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.7 | 4.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.7 | 7.3 | GO:0031045 | dense core granule(GO:0031045) |
| 0.6 | 1.9 | GO:0000806 | Y chromosome(GO:0000806) |
| 0.6 | 3.4 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.6 | 7.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.5 | 2.6 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.5 | 28.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.5 | 3.5 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.5 | 6.9 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.5 | 12.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.5 | 14.9 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.4 | 37.2 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.4 | 69.2 | GO:0030426 | growth cone(GO:0030426) |
| 0.4 | 5.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.4 | 7.7 | GO:0005922 | connexon complex(GO:0005922) |
| 0.4 | 9.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.4 | 12.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.4 | 3.9 | GO:0045180 | basal cortex(GO:0045180) |
| 0.3 | 9.8 | GO:0032420 | stereocilium(GO:0032420) |
| 0.3 | 4.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.3 | 28.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.3 | 9.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.3 | 1.9 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.3 | 12.2 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.3 | 4.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.3 | 15.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.3 | 18.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.3 | 4.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.3 | 14.4 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.3 | 15.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.3 | 5.8 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
| 0.3 | 41.2 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.2 | 6.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.2 | 3.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.2 | 4.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.2 | 5.3 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.2 | 21.8 | GO:0031514 | motile cilium(GO:0031514) |
| 0.2 | 7.8 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.2 | 18.7 | GO:0005814 | centriole(GO:0005814) |
| 0.2 | 15.7 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.2 | 7.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.2 | 2.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.2 | 4.4 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.2 | 1.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.2 | 3.5 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.2 | 21.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.2 | 2.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.2 | 12.9 | GO:0016459 | myosin complex(GO:0016459) |
| 0.2 | 3.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.2 | 37.4 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.1 | 7.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.1 | 10.6 | GO:0098793 | presynapse(GO:0098793) |
| 0.1 | 0.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.1 | 4.6 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.1 | 1.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 3.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.1 | 8.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 7.2 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.1 | 3.7 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
| 0.1 | 5.2 | GO:0043204 | perikaryon(GO:0043204) |
| 0.1 | 2.9 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.1 | 4.6 | GO:0042641 | actomyosin(GO:0042641) |
| 0.1 | 3.2 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
| 0.1 | 0.9 | GO:0030904 | retromer complex(GO:0030904) |
| 0.1 | 1.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 0.5 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.0 | 5.2 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 3.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.0 | 2.0 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 1.9 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 1.4 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.0 | 6.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.0 | 2.7 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.0 | 1.1 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 9.5 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.0 | 0.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.0 | 19.7 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.0 | 0.2 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.7 | 30.7 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 6.9 | 41.7 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
| 4.2 | 12.7 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 3.5 | 10.6 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 3.4 | 17.0 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 2.4 | 24.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 2.4 | 16.9 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 2.4 | 7.2 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
| 2.2 | 19.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 2.2 | 8.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 2.1 | 10.3 | GO:0052841 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 2.0 | 6.1 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 1.9 | 14.9 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 1.8 | 14.5 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 1.8 | 8.9 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 1.8 | 19.5 | GO:0008430 | selenium binding(GO:0008430) |
| 1.7 | 6.7 | GO:0008431 | vitamin E binding(GO:0008431) |
| 1.5 | 4.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 1.5 | 4.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 1.5 | 10.2 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 1.5 | 16.0 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 1.4 | 4.3 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 1.4 | 4.2 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
| 1.4 | 4.2 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 1.4 | 6.9 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 1.3 | 4.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 1.3 | 5.3 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 1.3 | 27.8 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 1.3 | 11.4 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 1.3 | 11.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 1.2 | 6.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 1.2 | 7.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 1.2 | 28.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 1.1 | 14.9 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 1.1 | 11.2 | GO:1990380 | Lys63-specific deubiquitinase activity(GO:0061578) Lys48-specific deubiquitinase activity(GO:1990380) |
| 1.1 | 7.7 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 1.1 | 18.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 1.1 | 4.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 1.1 | 17.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 1.1 | 3.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 1.0 | 3.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.9 | 21.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.9 | 5.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.9 | 9.7 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.9 | 6.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.8 | 26.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.8 | 5.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.8 | 3.3 | GO:0035473 | lipase binding(GO:0035473) |
| 0.8 | 15.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.8 | 13.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.7 | 4.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.7 | 2.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.7 | 7.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.7 | 2.1 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 0.7 | 9.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.7 | 11.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.7 | 17.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.7 | 7.5 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.7 | 13.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.7 | 7.9 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.6 | 1.9 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.6 | 11.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.6 | 6.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.6 | 14.5 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.6 | 12.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.6 | 20.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.6 | 3.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.6 | 7.5 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.5 | 4.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.5 | 1.6 | GO:0017057 | glucose-6-phosphate dehydrogenase activity(GO:0004345) 6-phosphogluconolactonase activity(GO:0017057) |
| 0.5 | 2.1 | GO:0035276 | ethanol binding(GO:0035276) |
| 0.5 | 7.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.5 | 2.0 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.5 | 17.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.5 | 7.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.5 | 1.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
| 0.4 | 4.0 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.4 | 3.1 | GO:0043559 | insulin binding(GO:0043559) |
| 0.4 | 44.5 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.4 | 4.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.4 | 9.7 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.4 | 13.5 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
| 0.4 | 10.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.4 | 3.3 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.4 | 2.8 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.4 | 5.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.4 | 12.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.4 | 1.4 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.4 | 2.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.4 | 2.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.3 | 15.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.3 | 2.8 | GO:0043426 | MRF binding(GO:0043426) |
| 0.3 | 9.6 | GO:0043394 | proteoglycan binding(GO:0043394) |
| 0.3 | 3.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.3 | 6.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.3 | 1.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.3 | 1.4 | GO:0070905 | serine binding(GO:0070905) |
| 0.3 | 7.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.3 | 13.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.3 | 11.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.3 | 1.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.3 | 23.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.3 | 4.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.3 | 3.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.3 | 5.5 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.2 | 3.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.2 | 6.3 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.2 | 3.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.2 | 6.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.2 | 2.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.2 | 2.0 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.2 | 6.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.2 | 11.0 | GO:0017022 | myosin binding(GO:0017022) |
| 0.2 | 16.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.2 | 2.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.2 | 5.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.2 | 1.4 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
| 0.2 | 8.9 | GO:0008146 | sulfotransferase activity(GO:0008146) |
| 0.2 | 3.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.2 | 9.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.2 | 2.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.2 | 2.1 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
| 0.2 | 0.6 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 0.2 | 1.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.2 | 2.8 | GO:0005522 | profilin binding(GO:0005522) |
| 0.2 | 3.1 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.1 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.1 | 9.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 2.9 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.1 | 13.7 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
| 0.1 | 1.3 | GO:0001948 | glycoprotein binding(GO:0001948) |
| 0.1 | 1.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.1 | 15.1 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
| 0.1 | 18.6 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.1 | 17.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 0.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 12.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 0.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 11.8 | GO:0019902 | phosphatase binding(GO:0019902) |
| 0.1 | 1.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.1 | 1.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.1 | 2.7 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 1.9 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.1 | 0.4 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.1 | 4.8 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.1 | 2.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.1 | 0.6 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.1 | 6.3 | GO:0030295 | protein kinase activator activity(GO:0030295) |
| 0.1 | 4.3 | GO:0015297 | antiporter activity(GO:0015297) |
| 0.1 | 2.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 10.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 0.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.1 | 2.8 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 7.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.1 | 7.1 | GO:0003774 | motor activity(GO:0003774) |
| 0.1 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.1 | 4.2 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.1 | 35.8 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.0 | 0.1 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.0 | 1.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.0 | 3.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.0 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.0 | 0.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 1.5 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 1.8 | GO:0005518 | collagen binding(GO:0005518) |
| 0.0 | 6.9 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.0 | 1.8 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
| 0.0 | 2.0 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
| 0.0 | 1.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.0 | 0.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.0 | 3.3 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.0 | 6.9 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
| 0.0 | 3.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 0.0 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.6 | 13.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.6 | 25.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.6 | 7.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.6 | 32.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.5 | 7.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.5 | 8.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.4 | 13.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.4 | 6.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.4 | 24.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.3 | 12.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.3 | 10.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.3 | 11.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.3 | 14.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.3 | 8.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.3 | 13.2 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.3 | 6.0 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.2 | 4.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.2 | 18.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.2 | 9.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.2 | 3.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.2 | 12.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.2 | 11.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.2 | 6.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.2 | 7.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.2 | 24.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.2 | 11.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.2 | 6.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.2 | 6.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 2.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 4.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.1 | 19.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 2.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.1 | 3.2 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 6.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 3.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 4.3 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 6.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 4.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.1 | 4.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.1 | 15.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 1.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 2.1 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 2.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 2.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.0 | 0.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.0 | 1.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 5.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 0.1 | PID ENDOTHELIN PATHWAY | Endothelins |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 12.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 1.0 | 13.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.9 | 30.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.8 | 19.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.8 | 20.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.8 | 15.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.7 | 28.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.6 | 19.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.6 | 18.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.5 | 14.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.5 | 5.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.5 | 21.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.5 | 9.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.5 | 14.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.5 | 11.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.4 | 7.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.4 | 15.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.4 | 5.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.4 | 5.9 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
| 0.4 | 17.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.4 | 6.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.3 | 17.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.3 | 11.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.3 | 3.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.3 | 15.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.3 | 10.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.3 | 1.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.3 | 2.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.3 | 16.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.3 | 8.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.2 | 9.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.2 | 16.2 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.2 | 3.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.2 | 4.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.2 | 4.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.2 | 1.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.2 | 7.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.2 | 2.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.2 | 2.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.2 | 2.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.2 | 12.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.2 | 2.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.1 | 4.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.1 | 3.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.1 | 5.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.1 | 1.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.1 | 3.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 2.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 1.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 1.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.1 | 1.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.1 | 1.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 4.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 0.8 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
| 0.1 | 1.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.1 | 1.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.1 | 2.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 4.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.1 | 1.9 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
| 0.1 | 1.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.0 | 17.1 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.0 | 1.3 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
| 0.0 | 3.7 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
| 0.0 | 0.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.0 | 0.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.0 | 0.2 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
| 0.0 | 10.2 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.0 | 0.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.0 | 2.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.0 | 0.5 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.0 | 0.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |